Bullfrog AI (BFRG) Competitors $1.48 +0.16 (+12.12%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$1.47 -0.01 (-0.68%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. ICCC, ATNM, ELUT, ZIVO, RLMD, ACRV, EGRX, BTAI, MDCX, and FGENShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include ImmuCell (ICCC), Actinium Pharmaceuticals (ATNM), Elutia (ELUT), ZIVO Bioscience (ZIVO), Relmada Therapeutics (RLMD), Acrivon Therapeutics (ACRV), Eagle Pharmaceuticals (EGRX), BioXcel Therapeutics (BTAI), Medicus Pharma (MDCX), and FibroGen (FGEN). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Its Competitors ImmuCell Actinium Pharmaceuticals Elutia ZIVO Bioscience Relmada Therapeutics Acrivon Therapeutics Eagle Pharmaceuticals BioXcel Therapeutics Medicus Pharma FibroGen Bullfrog AI (NASDAQ:BFRG) and ImmuCell (NASDAQ:ICCC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability. Which has more volatility and risk, BFRG or ICCC? Bullfrog AI has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, ImmuCell has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Is BFRG or ICCC more profitable? ImmuCell has a net margin of 6.23% compared to Bullfrog AI's net margin of 0.00%. ImmuCell's return on equity of 6.25% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Bullfrog AIN/A -195.35% -162.37% ImmuCell 6.23%6.25%3.87% Do institutionals and insiders hold more shares of BFRG or ICCC? 1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 13.5% of ImmuCell shares are owned by institutional investors. 24.7% of Bullfrog AI shares are owned by company insiders. Comparatively, 5.6% of ImmuCell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer BFRG or ICCC? In the previous week, ImmuCell had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 1 mentions for ImmuCell and 0 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.00 equaled ImmuCell'saverage media sentiment score. Company Overall Sentiment Bullfrog AI Neutral ImmuCell Neutral Which has stronger earnings & valuation, BFRG or ICCC? ImmuCell has higher revenue and earnings than Bullfrog AI. Bullfrog AI is trading at a lower price-to-earnings ratio than ImmuCell, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBullfrog AI$60K252.83-$6.99M-$0.76-1.95ImmuCell$26.49M2.14-$2.16M$0.1932.89 SummaryImmuCell beats Bullfrog AI on 9 of the 12 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.53M$2.23B$5.79B$10.46BDividend YieldN/AN/A5.61%4.57%P/E Ratio-1.9536.10348.8626.86Price / Sales252.8311.62555.40125.65Price / CashN/A59.0126.0131.15Price / Book2.6012.2415.996.50Net Income-$6.99M-$63.46M$3.29B$271.25M7 Day Performance12.12%5.00%200.40%3.27%1 Month Performance16.54%2.41%184.31%8.15%1 Year Performance-53.61%43.58%331.44%26.52% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI0.6842 of 5 stars$1.48+12.1%N/A-38.6%$13.53M$60K-1.954High Trading VolumeICCCImmuCell0.683 of 5 stars$5.77-3.0%N/A+73.6%$52.22M$26.49M30.3770News CoveragePositive NewsATNMActinium Pharmaceuticals2.1819 of 5 stars$1.65+1.5%$4.50+173.6%-9.4%$51.32MN/A-1.1830ELUTElutia3.1342 of 5 stars$1.22-0.4%$7.00+476.1%-72.3%$51.30M$23.68M-1.14180High Trading VolumeZIVOZIVO Bioscience0.1161 of 5 stars$13.31+2.4%N/A-16.1%$50.80M$15.85K-2.7310RLMDRelmada Therapeutics2.8431 of 5 stars$1.53-8.7%$5.00+227.9%-53.0%$50.62MN/A-0.6910ACRVAcrivon Therapeutics2.8279 of 5 stars$1.55+2.3%$15.00+870.9%-77.8%$48.61MN/A-0.6958Positive NewsEGRXEagle Pharmaceuticals1.3617 of 5 stars$3.73+16.0%N/A-14.9%$48.38M$257.55M0.00100Gap DownBTAIBioXcel Therapeutics3.8207 of 5 stars$3.00-5.5%$39.75+1,227.2%-69.9%$47.95M$868K-0.2490Gap DownMDCXMedicus Pharma2.4171 of 5 stars$2.68+8.1%$23.50+776.9%N/A$47.75MN/A-2.00N/AFGENFibroGen4.4167 of 5 stars$11.72-1.0%$43.00+266.9%+19.7%$47.35M$29.62M-30.84570Gap Down Related Companies and Tools Related Companies ImmuCell Competitors Actinium Pharmaceuticals Competitors Elutia Competitors ZIVO Bioscience Competitors Relmada Therapeutics Competitors Acrivon Therapeutics Competitors Eagle Pharmaceuticals Competitors BioXcel Therapeutics Competitors Medicus Pharma Competitors FibroGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
